Skip to main content
Equibles
AQST logo

AQST · Aquestive Therapeutics, Inc.

Track AQST — free

Use AQST with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about AQST

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.25 +0.00 (+0.00%) At close · Aug 14
Market Cap
$533.42M
Shares
125.51M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
19,637,240 +8.8% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
90/100
Short interest 14.4% of shares — P95 Days to cover 8.9 — P87 Price vs VWAP +1.6% — P55 Short-volume trend +10.7% — P85 Short interest change +8.2% — P76 Worst FTD 0.02% of shares — P54 Volume surge +10

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 Scheduled
    FINRA publishes Aug 25
    		 — — — —
    2026-07-31 18,048,004 16,674,440 +1,373,564 8.92
    2026-07-15 16,674,440 15,996,883 +677,557 10.90
    2026-06-30 15,996,883 14,797,738 +1,199,145 5.28
    2026-06-15 14,797,738 15,239,186 -441,448 9.55
    2026-05-29 15,239,186 15,033,627 +205,559 10.77
    2026-05-15 15,033,627 15,497,249 -463,622 7.43
    2026-04-30 15,497,249 15,520,449 -23,200 12.61
    2026-04-15 15,520,449 17,555,797 -2,035,348 15.66
    2026-03-31 17,555,797 17,684,928 -129,131 10.09
    2026-03-13 17,684,928 19,954,296 -2,269,368 7.34
    2026-02-27 19,954,296 20,036,340 -82,044 10.12
    2026-02-13 20,036,340 20,386,052 -349,712 2.27
    2026-01-30 20,386,052 20,296,603 +89,449 5.10
    2026-01-15 20,296,603 24,139,081 -3,842,478 2.26
    2025-12-31 24,139,081 21,919,352 +2,219,729 10.35
    2025-12-15 21,919,352 19,825,552 +2,093,800 10.05
    2025-11-28 19,825,552 19,196,523 +629,029 7.19
    2025-11-14 19,196,523 14,739,130 +4,457,393 5.89
    2025-10-31 14,739,130 12,252,965 +2,486,165 5.42
    2025-10-15 12,252,965 11,580,083 +672,882 3.80
    2025-09-30 11,580,083 8,880,063 +2,700,020 2.41
    2025-09-15 8,880,063 9,274,353 -394,290 2.64
    2025-08-29 9,274,353 8,411,354 +862,999 6.49
    Showing 1–23 of 23 settlements
    Key facts CIK 1398733 CUSIP 03843E104 13F (30d) 181 filings 177 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)